z-logo
open-access-imgOpen Access
Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
Author(s) -
N. Kamath,
Rita Patel,
Kamal Sharma,
NiravH Patel,
AnkitaM Thakkar
Publication year - 2014
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.140577
Subject(s) - metoprolol , nebivolol , medicine , blood pressure , essential hypertension , cost effectiveness , pharmacology , anesthesia , risk analysis (engineering)
To estimate and compare the cost-effectiveness and safety of nebivolol with sustained-release metoprolol in reducing blood pressure by 1 mm of Hg per day in hypertensive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom